Claudia Iavarone
[email protected] | |
Telephone | 0294375016 |
Location |
Building 1
Floor 1st Via Adamello 16, Milano |
Member of
I graduated in Medical Biotechnology at Università degli Studi di Napoli "Federico II" in Naples and I hold a PhD degree in Molecular Medicine from SEMM - European School of Molecular Medicine in Milan. I have 10 years experience in biomedical research, in particular in preclinical translation research in breast and ovarian cancer. From 2014 to 2018 I worked as Postdoctoral Fellow in the research group of Joan’s Brugge at Harvard Medical School in Boston (USA). I am co-author in several peer-reviewed scientific publications. I have competencies in general principles of clinical research, business administration and marketing &business development.
Most Relevant Publications
-
A Self-Sustaining Endocytic-Based Loop Promotes Breast Cancer Plasticity Leading to Aggressiveness and Pro-Metastatic Behavior.
Nat Commun, 2020
-
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness
Mol Cancer Ther, 2019
-
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response
Nat Commun, 2017
-
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
JCI Insight, 2016